Brain metastases in disseminated germinal neoplasms. Incidence and clinical course
Open Access
- 1 October 1979
- Vol. 44 (4) , 1514-1516
- https://doi.org/10.1002/1097-0142(197910)44:4<1514::aid-cncr2820440450>3.0.co;2-4
Abstract
From July 1973, to March 1978, 139 patients with disseminated germinal neoplasms were treated with a variety of combination chemotherapy regimens. Twenty‐one patients (15.1%) exhibited evidence of brain metastases at some time during their course. Central nervous system spread occurred somewhat more frequently in patients with choriocarcinoma and yolk sac histologies, although all types were at risk. This was a major cause of morbidity and mortality. However, central nervous system spread almost always occurred in patients with systemic relapse and thus did not affect overall survival. We have yet to identify a subgroup who potentially could benefit from prophylactic central nervous system therapy.This publication has 6 references indexed in Scilit:
- Central nervous system involvement by ovarian carcinoma.A complication of prolonged survival with metastatic diseaseCancer, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- TREATMENT OF METASTATIC GERM-CELL TUMORS IN MEN WITH ADRIAMYCIN, VINCRISTINE, AND BLEOMYCIN1977
- Combination chemotherapy in germinal cell tumorsCancer Treatment Reviews, 1976
- Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous systemCancer, 1976
- Platinum coordination complexes in cancer chemotherapyThe Science of Nature, 1973